Fujifilm Diosynth Biotechnologies Overview
- Year Founded
-
1994
- Status
-
Acquired/Merged
- Employees
-
4,200
- Latest Deal Type
-
Grant
- Financing Rounds
-
4
- Investments
-
3
Fujifilm Diosynth Biotechnologies General Information
Description
Manufacturer of pharmaceutical products based in College Station, Texas. The company offers advanced therapies, cell therapy, gene therapy, analytic services, cell line development, vaccines, insect cell culture and formulation development, thereby helping clients to accelerate their progress, expand capabilities, streamline processes and strengthen innovation.
Contact Information
Website
www.fujifilmdiosynth.com(Operating Subsidiary)
Corporate Office
- 3939 Fujifilm Way
- College Station, TX 77845
- United States
Corporate Office
- 3939 Fujifilm Way
- College Station, TX 77845
- United States
Fujifilm Diosynth Biotechnologies Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Fujifilm Diosynth Biotechnologies Comparisons
Industry
Financing
Details
000000
000 00
Fujifilm Diosynth Biotechnologies Competitors (37)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| FinVector | Corporation | Kuopio, Finland | 000 | |||
| CIS Bio International | Formerly PE-Backed | Saclay, France | 000 | 000000&0 | ||
| Lonza Group | Corporation | Basel, Switzerland | 00000 | 00.000 | 000000000000 | 00.000 |
| Athersys | Formerly VC-backed | Cleveland, OH | 00 | 00.000 | 000000&0 | 00.000 |
| Celonic | Corporate Backed or Acquired | Basel, Switzerland | 000 | 000000&0 |
Fujifilm Diosynth Biotechnologies Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Fujifilm Diosynth Biotechnologies Patents
Fujifilm Diosynth Biotechnologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20240286792-A1 | Packaging for breakable print products | Pending | 24-Feb-2023 | 0000000000 | |
| US-20240269189-A1 | Extracellular vesicle-enriched secretome composition derived from induced pluripotent stem cell derived-microglia and methods of use thereof | Pending | 19-Dec-2022 | 000000000 | |
| EP-4423253-A1 | Dopaminergic neurons comprising mutations and methods of use thereof | Pending | 28-Oct-2022 | ||
| CA-3216864-A1 | System and method for recreating a physical instant analog print developing experience for a digital photo | Pending | 17-Oct-2022 | 000000000 | |
| US-20240127506-A1 | System and method for recreating a physical instant analog print developing experience for a digital photo | Pending | 17-Oct-2022 | G06F9/451 | 0 |
Fujifilm Diosynth Biotechnologies Executive Team (12)
| Name | Title | Board Seat |
|---|---|---|
| Lars Petersen | Chief Executive Officer & President | |
| Richard McAvoy | Chief Financial Officer | |
| Patricia Colombo | Chief Compliance Officer & Vice President | |
| Ravi Narasimhan | Chief Information Officer & Senior Vice President | |
| Dennis Pedersen | Chief People Officer |
Fujifilm Diosynth Biotechnologies Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Fujifilm Diosynth Biotechnologies Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Fujifilm Diosynth Biotechnologies Investments & Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Atara Biotherapeutics (T-Cell Operations and Manufacturing Facility in Thousand Oaks, California) | 04-Apr-2022 | 000000000 | 00000 | Buildings and Property | 000000 00 |
| Biogen (Denmark Manufacturing Facility) | 01-Aug-2019 | 0000000000 | 00000 | Pharmaceuticals | 00000 000 |
| TeraMedica | 13-May-2015 | Merger/Acquisition | Other Healthcare Technology Systems |
Fujifilm Diosynth Biotechnologies FAQs
-
When was Fujifilm Diosynth Biotechnologies founded?
Fujifilm Diosynth Biotechnologies was founded in 1994.
-
Who is the CEO of Fujifilm Diosynth Biotechnologies?
Lars Petersen is the CEO of Fujifilm Diosynth Biotechnologies.
-
Where is Fujifilm Diosynth Biotechnologies headquartered?
Fujifilm Diosynth Biotechnologies is headquartered in College Station, TX.
-
What is the size of Fujifilm Diosynth Biotechnologies?
Fujifilm Diosynth Biotechnologies has 4,200 total employees.
-
What industry is Fujifilm Diosynth Biotechnologies in?
Fujifilm Diosynth Biotechnologies’s primary industry is Pharmaceuticals.
-
Is Fujifilm Diosynth Biotechnologies a private or public company?
Fujifilm Diosynth Biotechnologies is a Private company.
-
What is Fujifilm Diosynth Biotechnologies’s current revenue?
The current revenue for Fujifilm Diosynth Biotechnologies is 000000.
-
Who are Fujifilm Diosynth Biotechnologies’s investors?
Merck & Co. has invested in Fujifilm Diosynth Biotechnologies.
-
Who are Fujifilm Diosynth Biotechnologies’s competitors?
FinVector, CIS Bio International, Lonza Group, Athersys, and Celonic are some of the 37 competitors of Fujifilm Diosynth Biotechnologies.
-
When was Fujifilm Diosynth Biotechnologies acquired?
Fujifilm Diosynth Biotechnologies was acquired on 01-Jun-2021.
-
Who acquired Fujifilm Diosynth Biotechnologies?
Fujifilm Diosynth Biotechnologies was acquired by FujiFilm.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
